154 results
Page 2 of 8
8-K
EX-99.1
ha31ar
29 Mar 22
Pulmatrix Announces Year-End and Q4 Financial 2021 Results and Provides Corporate Update
9:15am
8-K
EX-99.1
4u1j7s meh6gvo
21 Mar 22
Pulmatrix Announces Positive Top-Line Data Evaluating PUR1800 in Patients with Stable COPD
8:15am
8-K
EX-99.1
r3n1mvq 3e6ce2913r6p
17 Mar 22
Other Events
4:15pm
8-K
EX-99.1
i2ih3 rlct8k
4 Mar 22
Pulmatrix Announces Expansion of Executive Leadership Team to Progress Clinical Pipeline
8:00am
8-K
EX-99.1
t95bq
24 Feb 22
Pulmatrix, Inc. Announces 1-for-20 Reverse Stock Split
4:10pm
DEFA14A
xe84imw4l7 w6n
1 Feb 22
Additional proxy soliciting materials
9:10am
DEFA14A
EX-99.1
6gsdkh lv
17 Dec 21
Additional proxy soliciting materials
5:03pm
8-K
EX-99.1
gt3xsus1an14nllnoo
17 Dec 21
Pulmatrix Announces Closing of $6.75 Million Registered Direct Offering
4:40pm
424B5
ujfd4fh mk6xno47ay
17 Dec 21
Prospectus supplement for primary offering
6:13am
DEFA14A
EX-3.1
wyfmt8 sn01a9ggopy
17 Dec 21
Additional proxy soliciting materials
6:09am
8-K/A
EX-3.1
e2ylq7q7 ek6
17 Dec 21
Entry into a Material Definitive Agreement
6:08am
DEFA14A
EX-99.1
xzljer0f1xb6vqo71k
15 Dec 21
Additional proxy soliciting materials
5:27pm
DEFA14A
EX-3.1
t626mj
15 Dec 21
Additional proxy soliciting materials
5:27pm
DEFA14A
EX-10.1
zh3p4cwf
15 Dec 21
Additional proxy soliciting materials
5:27pm
8-K
EX-3.1
nveizace0yvdgq7jo7f
15 Dec 21
Pulmatrix Announces $6.75 Million Registered Direct Offering
5:27pm
8-K
EX-10.1
bieqmi03va2b
15 Dec 21
Pulmatrix Announces $6.75 Million Registered Direct Offering
5:27pm
8-K
EX-99.1
d8hgkrmh pn5si0zofq
15 Dec 21
Pulmatrix Announces $6.75 Million Registered Direct Offering
5:27pm
8-K
EX-99.1
hy4dqm7
10 Nov 21
Pulmatrix Reports Third Quarter 2021 Financial Results and Provides Business Update
4:20pm